Penalty for a pharmaceutical manufacturer's misrepresentation of average sales price of a drug, or biologic · 1395w-3a(d)(4)(A)

For Penalty for a pharmaceutical manufacturer's misrepresentation of average sales price of a drug, or biologic, statutory authority is 1395w-3a(d)(4)(A); agency is HHS; maximum penalty is 17,062, recorded from its source on 2026-08-10.

Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.

What the source says

1395w-3a(d)(4)(A) | 42 CFR 414.806 | CMS | Penalty for a pharmaceutical manufacturer's misrepresentation of average sales price of a drug, or biologic | 2024 | 16,630 | 17,062

— ecfr.gov, retrieved 2026-08-10

Source

• ecfr.govhttps://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-102/section-102.3

Last verified against source: 2026-08-10. Due for re-check by 2027-02-26. This page as Markdown · OKF bundle · full dataset as JSON.